A new suite of media for cardiotoxicity and drug discovery studies with human iPSC-derived cardiomyocytes

被引：0
|
作者：
Filali, O. [1 ]
Armstrong, A. [1 ]
Livingston, M. [1 ]
Carlson, C. [1 ]
Rieger, C. [1 ]
Meyer, N. [1 ]
Vaidyanathan, R. [1 ]
Rajesh, D. [1 ]
机构：
[1] FUJIFILM Cellular Dynam Inc, Madison, WI USA
来源：
TOXICOLOGY LETTERS | 2022年 / 368卷
关键词：
D O I：
10.1016/j.toxlet.2022.07.224
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
SOC-VI-04
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [31] Cardiotoxicity testing in human iPSC-derived cardiomyocytes for the CiPA pilot study using all-optical electrophysiology
    Dempsey, Graham
    Atwater, Nicholas
    Cuong Nguyen
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2016, 81 : 381 - 381
  • [32] Adaptation of Human iPSC-Derived Cardiomyocytes to Tyrosine Kinase Inhibitors Reduces Acute Cardiotoxicity via Metabolic Reprogramming
    Wang, Huan
    Sheehan, Robert P.
    Palmer, Adam C.
    Everley, Robert A.
    Boswell, Sarah A.
    Ron-Harel, Noga
    Ringel, Alison E.
    Holton, Kristina M.
    Jacobson, Connor A.
    Erickson, Alison R.
    Maliszewski, Laura
    Haigis, Marcia C.
    Sorger, Peter K.
    [J]. CELL SYSTEMS, 2019, 8 (05) : 412 - +
  • [33] Proposal for considerations during human iPSC-derived cardiac organoid generation for cardiotoxicity drug testing
    Lee, Sang Woo
    Song, Myeongjin
    Woo, Dong-Hun
    Jeong, Gi Seok
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
  • [34] High throughput physiological screening of iPSC-derived cardiomyocytes for drug development
    del Alamo, Juan C.
    Lemons, Derek
    Serrano, Ricardo
    Savchenko, Alex
    Cerignoli, Fabio
    Bodmer, Rolf
    Mercola, Mark
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2016, 1863 (07): : 1717 - 1727
  • [35] Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes
    Lapp, Hendrik
    Bruegmann, Tobias
    Malan, Daniela
    Friedrichs, Stephanie
    Kilgus, Carsten
    Heidsieck, Alexandra
    Sasse, Philipp
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [36] Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential
    Yamamoto, Wataru
    Asakura, Keiichi
    Ando, Hiroyuki
    Taniguchi, Tomohiko
    Ojima, Atsuko
    Uda, Takaaki
    Osada, Tomoharu
    Hayashi, Seiji
    Kasai, Chieko
    Miyamoto, Norimasa
    Tashibu, Hiroyuki
    Yoshinaga, Takashi
    Yamazaki, Daiju
    Sugiyama, Atsushi
    Kanda, Yasunari
    Sawada, Kohei
    Sekino, Yuko
    [J]. PLOS ONE, 2016, 11 (12):
  • [37] Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes
    Hendrik Lapp
    Tobias Bruegmann
    Daniela Malan
    Stephanie Friedrichs
    Carsten Kilgus
    Alexandra Heidsieck
    Philipp Sasse
    [J]. Scientific Reports, 7
  • [38] iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery
    Corbett, James L.
    Duncan, Stephen A.
    [J]. FRONTIERS IN MEDICINE, 2019, 6
  • [39] Cardiotoxicity screening of illicit drugs and new psychoactive substances (NPS) in human iPSC-derived cardiomyocytes using microelectrode array (MEA) recordings
    Zwartsen, Anne
    de Korte, Tessa
    Nacken, Peter
    de Lange, Dylan W.
    Westerink, Remco H. S.
    Hondebrink, Laura
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 136 : 102 - 112
  • [40] Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery
    Sharma, Arun
    Sances, Samuel
    Workman, Michael J.
    Svendsen, Clive N.
    [J]. CELL STEM CELL, 2020, 26 (03) : 309 - 329
12345